Phase 3 and Extensional Study of Besifovir

Clinical trial NCT01937806 · UNKNOWN

Trial details

NCT number: NCT01937806
Sponsor: IlDong Pharmaceutical Co Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2013-10-01
Primary completion: 2016-02-01
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.